| Financial Year |
March 31 2023 |
| Monetary Funds |
163,851,630.17 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
338,813,095.08 |
| Advances to Suppliers |
77,737,795.19 |
| Other Receivables |
171,574,698.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
626,172,310.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
11,825,135.98 |
| Other Current Assets |
37,960,121.52 |
| Total Current Assets |
1,427,934,786.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
33,551,467.47 |
| Long-term Equity Investment |
620,605,928.47 |
| Investment Properties |
556,505,000.00 |
| Fixed Assetes |
658,841,536.21 |
| Under-construction Projects |
6,644,051.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,129,893.16 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,250,155.19 |
| Deferred Income Tax Assets |
46,024,393.20 |
| Other Non-Current Assets |
7,835,724.41 |
| Sub-Total of Non-Current Assets |
2,095,437,234.22 |
| Total Assets |
3,523,372,020.74 |
| Short-Term Loans |
952,214,805.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
221,259,619.99 |
| Accounts Payable |
584,761,935.61 |
| Accounts Received In Advance |
3,564,403.22 |
| Employee Compensation Payable |
48,450,790.30 |
| Taxes Payable |
115,941,428.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,048,366,205.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
32,928,707.16 |
| Other Current Liabilities |
28,772,402.48 |
| Sub-Total of Current Liabilities |
3,084,821,590.48 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
46,024,393.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
147,880,847.26 |
| Total Liabilities |
3,232,702,437.74 |
| Paid-In Capital(Or Share Stock) |
2,512,500,000.00 |
| Capital Surplus |
161,473,544.98 |
| Surplus Reserve |
523,409,141.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,997,548,882.48 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
290,669,583.00 |
| Owner's Equity（Stockholder's Equity） |
290,669,583.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,523,372,020.74 |
